Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K
Nagoya University Branch Hospital, Japan.
Nephrol Dial Transplant. 1997 May;12(5):889-98. doi: 10.1093/ndt/12.5.889.
Beginning in 1966, the Patient Registration Committee of the Japanese Society for Dialysis Therapy has conducted a survey once a year on renal replacement therapy in Japan. As of 1983, the survey covered the life/death of patients in the survey years, as well as the case mix of individual patients. In 1990 several laboratory variables were added to the survey items. The present report summarizes the data from the 1993 and 1994 surveys. The Committee mailed out questionnaire forms at the end of the survey year to the heads of all dialysis facilities. Survey forms were returned from 99.6% of the dialysis facilities in the 1993 survey, and from 99.8% of the facilities in the 1994 survey. Some 143709 patients were treated by renal replacement therapy in 1994 (7509 were treated by CAPD, and 131016 by extracorporeal haemopurification). The gross mortality rate was 9.5% in the same year. The mean values of the laboratory variables among 88693 patients undergoing thrice weekly haemodialysis were as follows in 1993: Kt/V, 1.31 +/- 0.30; protein catabolic rate, 1.04 +/- 0.30 g/kg/day; haemodialysis time, 4.12 +/- 0.50 h. In 1994, the variables were: predialysis serum creatinine concentration, 11.54 +/- 2.85 mg/dl; predialysis serum albumin concentration, 3.91 +/- 0.55 g/dl; predialysis haematocrit, 28.69 +/- 4.36%.
自1966年起，日本透析治疗学会患者登记委员会每年对日本的肾脏替代治疗情况进行一次调查。截至1983年，该调查涵盖了调查年份患者的生死情况以及个体患者的病例组合。1990年，若干实验室指标被纳入调查项目。本报告总结了1993年和1994年调查的数据。委员会在调查年份结束时向所有透析机构负责人邮寄了调查问卷。1993年调查中99.6%的透析机构返回了调查问卷，1994年这一比例为99.8%。1994年约有143709名患者接受了肾脏替代治疗（7509人接受持续性非卧床腹膜透析治疗，131016人接受体外血液净化治疗）。同年总死亡率为9.5%。1993年，88693名每周接受三次血液透析的患者的实验室指标平均值如下：尿素清除率（Kt/V）为1.31±0.30；蛋白质分解代谢率为1.04±0.30克/千克/天；血液透析时间为4.12±0.50小时。1994年，这些指标为：透析前血清肌酐浓度为11.54±2.85毫克/分升；透析前血清白蛋白浓度为3.91±0.55克/分升；透析前血细胞比容为28.69±4.36%。
